ANGI-03. PSA-NCAM IN GLIOBLASTOMA – A NEGATIVE PROGNOSTIC MARKER AND A THERAPEUTIC TARGET?

MLA

Jena Macapagal, et al. “Angi-03. Psa-Ncam in Glioblastoma – a Negative Prognostic Marker and a Therapeutic Target?” Neuro-Oncology, vol. 20, Nov. 2018, pp. vi28-vi29. EBSCOhost, https://doi.org/10.1093/neuonc/noy148.105.

APA

Jena Macapagal, Mike Dragunow, Thomas I. H. Park, Bernard J.H. Kim, Patrick Schweder, Clinton Turner, Peter Heppner, Birger Dieriks, & Maurice A. Curtis. (2018). Angi-03. Psa-Ncam in Glioblastoma – a Negative Prognostic Marker and a Therapeutic Target? Neuro-Oncology, 20, vi28-vi29. https://doi.org/10.1093/neuonc/noy148.105

Chicago

Jena Macapagal, Mike Dragunow, Thomas I. H. Park, Bernard J.H. Kim, Patrick Schweder, Clinton Turner, Peter Heppner, Birger Dieriks, and Maurice A. Curtis. 2018. “Angi-03. Psa-Ncam in Glioblastoma – a Negative Prognostic Marker and a Therapeutic Target?” Neuro-Oncology 20 (November): vi28-vi29. doi:10.1093/neuonc/noy148.105.